Designing Paclitaxel Drug Delivery Systems Aimed at Improved Patient Outcomes: Current Status and Challenges
Figure 12
Comparison of treatment of Diluent 12 and emulsion on the ascitic tumor bearing mice. □ represents untreated control, ▴ represents group treated with 30 mg/kg emulsion, and ● represents group treated with Diluent 12 (reproduced with permission from Kan et al., [61]).
